The changes of serum soluble intercellular adhesion molecule-1 after systemic steroid treatment in vitiligo

J Dermatol Sci. 1999 Dec;22(1):11-6. doi: 10.1016/s0923-1811(99)00035-3.

Abstract

Cell surface adhesion molecules are thought to play an important role in establishing intercellular contacts that are necessary for immunological reactions. Intercellular adhesion molecule-1 (ICAM-1, CD54) is a crucial adhesion molecule in mediating cell to cell adhesion during inflammatory responses, including non-MHC-restricted cytotoxicity. In this study, the sICAM-1 levels of ten healthy control subjects and seven generalized active vitiligo patients were measured by ELISA. The sICAM-1 levels were also correlated with the clinical courses in 33 patients with active vitiligo, who received systemic steroid treatment for 3 months. The average serum level of sICAM-1 was significantly higher in patients with active vitiligo than in the healthy control subjects. The sICAM-1 levels significantly decreased after systemic steroid treatment in the clinically improved group. These results suggest that immune activation is involved in active vitiligo and that changes of sICAM-1 levels can be a marker in the course of vitiliginous lesions.

MeSH terms

  • Adult
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Intercellular Adhesion Molecule-1 / blood*
  • Male
  • Steroids / therapeutic use*
  • Vitiligo / blood*
  • Vitiligo / drug therapy

Substances

  • Steroids
  • Intercellular Adhesion Molecule-1